X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. FRESENIUS KABI ONCO. FDC LTD./
FRESENIUS KABI ONCO.
 
P/E (TTM) x 29.0 22.1 131.2% View Chart
P/BV x 6.1 3.1 194.4% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 FDC LTD.   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    FDC LTD.
Mar-14
FRESENIUS KABI ONCO.
Mar-13
FDC LTD./
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs144176 81.5%   
Low Rs7979 100.6%   
Sales per share (Unadj.) Rs47.637.7 126.2%  
Earnings per share (Unadj.) Rs7.65.1 149.4%  
Cash flow per share (Unadj.) Rs9.06.7 134.0%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.542.5 111.7%  
Shares outstanding (eoy) m177.83158.23 112.4%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.33.4 69.3%   
Avg P/E ratio x14.625.0 58.5%  
P/CF ratio (eoy) x12.318.9 65.2%  
Price / Book Value ratio x2.33.0 78.2%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,78420,135 98.3%   
No. of employees `000NA1.2 0.0%   
Total wages/salary Rs m1,221703 173.6%   
Avg. sales/employee Rs ThNM5,176.2-  
Avg. wages/employee Rs ThNM610.4-  
Avg. net profit/employee Rs ThNM699.6-  
INCOME DATA
Net Sales Rs m8,4595,963 141.8%  
Other income Rs m39418 2,186.4%   
Total revenues Rs m8,8525,981 148.0%   
Gross profit Rs m2,0701,430 144.8%  
Depreciation Rs m249258 96.6%   
Interest Rs m31-26 -119.3%   
Profit before tax Rs m2,1841,216 179.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m606342 177.0%   
Profit after tax Rs m1,353806 167.9%  
Gross profit margin %24.524.0 102.0%  
Effective tax rate %27.728.1 98.6%   
Net profit margin %16.013.5 118.4%  
BALANCE SHEET DATA
Current assets Rs m4,3555,102 85.4%   
Current liabilities Rs m1,7922,385 75.1%   
Net working cap to sales %30.345.6 66.5%  
Current ratio x2.42.1 113.6%  
Inventory Days Days44150 29.6%  
Debtors Days Days25113 21.8%  
Net fixed assets Rs m3,0255,148 58.8%   
Share capital Rs m179158 112.9%   
"Free" reserves Rs m8,2436,556 125.7%   
Net worth Rs m8,4536,732 125.6%   
Long term debt Rs m11952 1.1%   
Total assets Rs m10,55710,388 101.6%  
Interest coverage x71.4-45.8 -156.0%   
Debt to equity ratio x00.1 0.9%  
Sales to assets ratio x0.80.6 139.6%   
Return on assets %13.17.5 174.6%  
Return on equity %16.012.0 133.7%  
Return on capital %23.514.6 161.0%  
Exports to sales %13.374.5 17.9%   
Imports to sales %3.324.8 13.5%   
Exports (fob) Rs m1,1264,441 25.4%   
Imports (cif) Rs m2831,477 19.1%   
Fx inflow Rs m1,1465,298 21.6%   
Fx outflow Rs m3551,772 20.0%   
Net fx Rs m7913,525 22.4%   
CASH FLOW
From Operations Rs m1,4851,274 116.5%  
From Investments Rs m-620-1,204 51.4%  
From Financial Activity Rs m-753-196 383.7%  
Net Cashflow Rs m113-126 -89.3%  

Share Holding

Indian Promoters % 68.9 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 4.7 0.3 1,566.7%  
FIIs % 7.5 9.6 78.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 9.1 208.8%  
Shareholders   23,730 42,599 55.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   GLENMARK PHARMA  UNICHEM LAB  DR. REDDYS LAB  DIVIS LABORATORIES  ALEMBIC LTD  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Down Around 1%; Telecom & Metal Stocks Decline(01:30 pm)

Indian share markets are trading in the red presently. Sectoral indices are trading in the red with stocks in the telecom sector and metal sector witnessing maximum selling pressure.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Feb 19, 2018 01:59 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS